IS2980B - Methods for Preparation of 4 - [[4 - [[4- (2-cyanoethyl) -2,6-dimethylphenyl] amino] -2-pyrimidinyl] amino] benzonitrile - Google Patents

Methods for Preparation of 4 - [[4 - [[4- (2-cyanoethyl) -2,6-dimethylphenyl] amino] -2-pyrimidinyl] amino] benzonitrile

Info

Publication number
IS2980B
IS2980B IS7621A IS7621A IS2980B IS 2980 B IS2980 B IS 2980B IS 7621 A IS7621 A IS 7621A IS 7621 A IS7621 A IS 7621A IS 2980 B IS2980 B IS 2980B
Authority
IS
Iceland
Prior art keywords
amino
cyanoethyl
benzonitrile
dimethylphenyl
pyrimidinyl
Prior art date
Application number
IS7621A
Other languages
Icelandic (is)
Other versions
IS7621A (en
Inventor
Philippe Robert Schils Didier
Josephus Maria Willems Joannes
Petrus Anna Maria Jozef Medaer Bart
Therese Jeanne Pasquier Elisabeth
Adriaan Jan Janssen Paul
Heeres Jan
Gerardus George Leenders Ruben
Emile Georges Guillemont Jérome
Original Assignee
Janssen Pharmaceutica N.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=31725448&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IS2980(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Janssen Pharmaceutica N.V. filed Critical Janssen Pharmaceutica N.V.
Publication of IS7621A publication Critical patent/IS7621A/en
Publication of IS2980B publication Critical patent/IS2980B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48—Two nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C253/00—Preparation of carboxylic acid nitriles
    • C07C253/20—Preparation of carboxylic acid nitriles by dehydration of carboxylic acid amides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C253/00—Preparation of carboxylic acid nitriles
    • C07C253/30—Preparation of carboxylic acid nitriles by reactions not involving the formation of cyano groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
IS7621A 2002-08-09 2004-12-29 Methods for Preparation of 4 - [[4 - [[4- (2-cyanoethyl) -2,6-dimethylphenyl] amino] -2-pyrimidinyl] amino] benzonitrile IS2980B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP02078306 2002-08-09
PCT/EP2003/050366 WO2004016581A1 (en) 2002-08-09 2003-08-07 Processes for the preparation of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2-pyrimidinyl]amino]benzonitrile

Publications (2)

Publication Number Publication Date
IS7621A IS7621A (en) 2004-12-29
IS2980B true IS2980B (en) 2017-09-15

Family

ID=31725448

Family Applications (1)

Application Number Title Priority Date Filing Date
IS7621A IS2980B (en) 2002-08-09 2004-12-29 Methods for Preparation of 4 - [[4 - [[4- (2-cyanoethyl) -2,6-dimethylphenyl] amino] -2-pyrimidinyl] amino] benzonitrile

Country Status (27)

Country Link
US (3) US7399856B2 (en)
EP (1) EP1529032B1 (en)
JP (1) JP4822707B2 (en)
KR (2) KR101140785B1 (en)
CN (4) CN101481356B (en)
AR (1) AR040964A1 (en)
AU (1) AU2003266413B2 (en)
BR (1) BR0313545B1 (en)
CA (2) CA2686429C (en)
CL (1) CL2010000284A1 (en)
CY (1) CY1114428T1 (en)
DK (1) DK1529032T3 (en)
EA (1) EA007953B1 (en)
ES (1) ES2422196T3 (en)
HK (4) HK1081527A1 (en)
HR (1) HRP20050104B1 (en)
IL (1) IL166710A (en)
IS (1) IS2980B (en)
MX (1) MXPA05001541A (en)
MY (1) MY144894A (en)
NO (1) NO330013B1 (en)
NZ (1) NZ538611A (en)
PL (1) PL208533B1 (en)
PT (1) PT1529032E (en)
SI (1) SI1529032T1 (en)
TW (1) TWI314146B (en)
WO (1) WO2004016581A1 (en)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8101629B2 (en) * 2001-08-13 2012-01-24 Janssen Pharmaceutica N.V. Salt of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2-pyrimidinyl]amino]benzonitrile
MY169670A (en) 2003-09-03 2019-05-08 Tibotec Pharm Ltd Combinations of a pyrimidine containing nnrti with rt inhibitors
US7638522B2 (en) 2001-08-13 2009-12-29 Janssen Pharmaceutica N.V. Salt of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2-pyrimidinyl]amino] benzonitrile
JO3429B1 (en) 2001-08-13 2019-10-20 Janssen Pharmaceutica Nv Hiv inhibiting pyrimidines derivatives
PL208533B1 (en) * 2002-08-09 2011-05-31 Janssen Pharmaceutica Nv Processes for the preparation of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2-pyrimidinyl]amino]benzonitrile
CN1717396A (en) * 2002-11-28 2006-01-04 舍林股份公司 Chk-, Pdk- and Akt-inhibitory pyrimidines, their production and use as pharmaceutical agents
WO2005123662A1 (en) * 2004-06-18 2005-12-29 Janssen Pharmaceutica N.V. Modified heck reaction
SI1789139T1 (en) * 2004-09-02 2012-08-31 Janssen Pharmaceutica Nv Fumarate of 4-((4-((4-(2-cyanoethenyl)-2,6-dimethylphenyl amino -2-pyrimidinyl amino benzonitrile
KR101284361B1 (en) * 2004-09-02 2013-07-15 얀센 파마슈티카 엔.브이. Hydrochloride of 4-((4-(4-(2-cyanoethenyl)-2,6-dimethylphenyl)amino)-2-pyrimidinyl)amino)benzonitrile
UA92469C2 (en) * 2004-09-02 2010-11-10 Янссен Фармацевтика Н.В. Fumarate of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2-pyrimidinyl amino benzonitrile
ES2371442T7 (en) * 2004-09-02 2022-05-12 Janssen Pharmaceutica Nv 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2-pyrimidinyl]amino]benzonitrile salt
AP2487A (en) * 2004-09-02 2012-10-03 Janssen Pharmaceutica Nv Fumarate of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]-amino]-2-pyrimidinyl]amino]benzonitrile
US7314962B2 (en) * 2005-04-15 2008-01-01 E. I. Du Pont De Nemours & Co. Alkylation of aromatic compounds
EP1888537B1 (en) 2005-05-26 2013-09-11 Janssen R&D Ireland Process for preparing 4-[(1,6-dihydro-6-oxo-2-pyrimidinyl)amino benzonitrile
CL2008000746A1 (en) 2007-03-14 2008-09-22 Tibotec Pharm Ltd PHARMACEUTICAL COMPOSITION IN SOLUTION INCLUDING TMC278 AND A WATER SOLUBLE POLYMER; PREPARATION PROCESS OF SUCH COMPOSITION; AND USE OF A POWDER UNDERSTANDING TMC278 TO TREAT AIDS.
CN101743006B (en) * 2007-07-12 2013-09-11 泰博特克药品公司 Crystalline form of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2 pyrimidinyl]amino]benzonitrile
WO2012125993A1 (en) 2011-03-17 2012-09-20 Teva Pharmaceutical Industries Ltd. Solid state forms of rilpivirine base, and rilipivirine salts
JP5870183B2 (en) * 2011-04-15 2016-02-24 エムキュア ファーマシューティカルズ リミテッド Method for the synthesis of rilpivirine intermediate
EP2702044B1 (en) 2011-04-25 2017-03-22 Hetero Research Foundation Process for rilpivirine
EP2755959B1 (en) * 2011-09-16 2018-05-16 Hetero Research Foundation Rilpivirine hydrochloride
WO2013170421A1 (en) * 2012-05-14 2013-11-21 上海迪赛诺药业有限公司 Rilpivirine hydrochloride alcoholate polymorph and preparation method thereof
WO2013179105A1 (en) * 2012-06-01 2013-12-05 Laurus Labs Private Limited Improved process for preparation of rilpivirine and pharmaceutically acceptable salts thereof
EP2872492B1 (en) * 2012-07-12 2018-01-31 Hetero Research Foundation Process for the preparation of rilpivirine using a novel intermediate
CZ201532A3 (en) 2015-01-21 2015-02-25 Zentiva, K.S. Process for preparing extremely pure rilpivirine and salt thereof
CN106008366A (en) * 2016-05-25 2016-10-12 山东大学 Preparation method of rilpivirine
HUE064823T2 (en) 2016-10-24 2024-04-28 Janssen Sciences Ireland Unlimited Co Dispersible compositions
US20210380540A1 (en) 2018-10-25 2021-12-09 Minakem Process for the preparation of rilpivirine
CN110526873B (en) * 2019-08-15 2022-09-16 复旦大学 Cyanovinyl substituted benzodiarylpyrimidine compound and preparation method and application thereof
CN115397422A (en) 2019-11-29 2022-11-25 西皮欧生命科学有限公司 Compositions comprising rilpivirine and their use for treating tumors or cancers
CN112010810B (en) * 2020-09-09 2024-01-30 瑞阳制药股份有限公司 Method for preparing high-purity rilpivirine intermediate by one-pot method
CN112778214A (en) * 2021-01-13 2021-05-11 安徽贝克联合制药有限公司 Intermediate for synthesizing rilpivirine, synthesis method thereof and rilpivirine synthesis method

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3459731A (en) 1966-12-16 1969-08-05 Corn Products Co Cyclodextrin polyethers and their production
DE2861560D1 (en) 1977-11-28 1982-03-04 Barry Boettcher Complexes of bivalent copper, methods of preparation thereof and compositions containing said complexes
US5691364A (en) 1995-03-10 1997-11-25 Berlex Laboratories, Inc. Benzamidine derivatives and their use as anti-coagulants
GB9523675D0 (en) 1995-11-20 1996-01-24 Celltech Therapeutics Ltd Chemical compounds
NZ322907A (en) 1995-11-23 1998-12-23 Janssen Pharmaceutica Nv Solid mixtures of cyclodextrins prepared via melt-extrusion
GB9705361D0 (en) 1997-03-14 1997-04-30 Celltech Therapeutics Ltd Chemical compounds
WO1999050250A1 (en) * 1998-03-27 1999-10-07 Janssen Pharmaceutica N.V. Hiv inhibiting pyrimidine derivatives
BRPI9909191B8 (en) 1998-03-27 2021-07-06 Janssen Pharmaceutica Nv hiv inhibitor pyrimidine derivatives, their use and pharmaceutical composition comprising them
JP2000035628A (en) 1998-07-16 2000-02-02 Konica Corp Silver halide photographic sensitive material
ES2274634T3 (en) 1998-08-29 2007-05-16 Astrazeneca Ab PIRIMIDINE COMPOUNDS.
KR100658489B1 (en) 1998-11-10 2006-12-18 얀센 파마슈티카 엔.브이. HIV replication inhibiting pyrimidines
SK12582001A3 (en) 1999-03-09 2002-02-05 Pharmacia & Upjohn Company 4-OXO-4,7-DIHYDRO-THIENO[2,3-b]PYRIDINE-5-CARBOXAMIDES AS ANTIVIRAL AGENTS
JP3989175B2 (en) 1999-04-15 2007-10-10 ブリストル−マイヤーズ スクイブ カンパニー Cyclic protein tyrosine kinase inhibitor
GB9914258D0 (en) 1999-06-18 1999-08-18 Celltech Therapeutics Ltd Chemical compounds
KR100785360B1 (en) 1999-09-24 2007-12-18 얀센 파마슈티카 엔.브이. Antiviral compositions
DE19945982A1 (en) 1999-09-24 2001-03-29 Knoll Ag Velocity-determined particles
US20030004174A9 (en) 2000-02-17 2003-01-02 Armistead David M. Kinase inhibitors
GB0004887D0 (en) 2000-03-01 2000-04-19 Astrazeneca Uk Ltd Chemical compounds
GB0004888D0 (en) 2000-03-01 2000-04-19 Astrazeneca Uk Ltd Chemical compounds
WO2001085700A2 (en) * 2000-05-08 2001-11-15 Janssen Pharmaceutica N.V. Hiv replication inhibiting pyrimidines and triazines
US6596729B2 (en) * 2000-07-20 2003-07-22 Bristol-Myers Squibb Company Tricyclic-2-pyridone compounds useful as HIV reverse transcriptase inhibitors
EP1363877A2 (en) 2001-03-02 2003-11-26 SmithKline Beecham Corporation Benzophenones as inhibitors of reverse transcriptase
DE60223790D1 (en) 2001-03-29 2008-01-10 Vertex Pharma HEMMER OF C-JUN TERMINAL KINASE (JNK) AND OTHER PROTEIN KINASE
MY169670A (en) 2003-09-03 2019-05-08 Tibotec Pharm Ltd Combinations of a pyrimidine containing nnrti with rt inhibitors
JO3429B1 (en) * 2001-08-13 2019-10-20 Janssen Pharmaceutica Nv Hiv inhibiting pyrimidines derivatives
WO2003020210A2 (en) 2001-08-29 2003-03-13 Umd, Inc. Vaginal delivery of chemotherapeutic agents and inhibitors of membrane efflux systems for cancer therapy
TWI329105B (en) 2002-02-01 2010-08-21 Rigel Pharmaceuticals Inc 2,4-pyrimidinediamine compounds and their uses
EA008244B1 (en) 2002-05-03 2007-04-27 Янссен Фармацевтика Н.В. Polymeric microemulsions
PL208533B1 (en) * 2002-08-09 2011-05-31 Janssen Pharmaceutica Nv Processes for the preparation of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2-pyrimidinyl]amino]benzonitrile
WO2004050068A1 (en) 2002-11-29 2004-06-17 Janssen Pharmaceutica N.V. Pharmaceutical compositions comprising a basic respectively acidic drug compound, a surfactant and a physiologically tolerable water-soluble acid respectively base

Also Published As

Publication number Publication date
NZ538611A (en) 2007-03-30
JP2005537303A (en) 2005-12-08
PL373679A1 (en) 2005-09-05
CN102702111B (en) 2014-12-17
CA2686429C (en) 2010-11-16
EP1529032A1 (en) 2005-05-11
JP4822707B2 (en) 2011-11-24
IL166710A (en) 2010-12-30
IS7621A (en) 2004-12-29
CN100554245C (en) 2009-10-28
PL208533B1 (en) 2011-05-31
KR101140785B1 (en) 2012-05-03
IL166710A0 (en) 2006-01-15
ES2422196T3 (en) 2013-09-09
HK1081527A1 (en) 2006-05-19
BR0313545A (en) 2005-07-12
CN101481356A (en) 2009-07-15
US7705148B2 (en) 2010-04-27
EA200500325A1 (en) 2005-06-30
CN102702111A (en) 2012-10-03
BR0313545B1 (en) 2021-07-27
CN102225902B (en) 2013-04-24
HK1161869A1 (en) 2012-08-10
EA007953B1 (en) 2007-02-27
CL2010000284A1 (en) 2010-08-20
EP1529032B1 (en) 2013-04-24
HK1129671A1 (en) 2009-12-04
CY1114428T1 (en) 2016-08-31
US20080167464A1 (en) 2008-07-10
KR20050040906A (en) 2005-05-03
MXPA05001541A (en) 2005-04-19
NO330013B1 (en) 2011-02-07
CA2686429A1 (en) 2004-02-26
NO20050524L (en) 2005-02-01
DK1529032T3 (en) 2013-07-08
KR101086678B1 (en) 2011-11-25
WO2004016581A1 (en) 2004-02-26
HRP20050104B1 (en) 2014-02-14
CN102225902A (en) 2011-10-26
AU2003266413A1 (en) 2004-03-03
US7399856B2 (en) 2008-07-15
KR20100127889A (en) 2010-12-06
HRP20050104A2 (en) 2006-03-31
TWI314146B (en) 2009-09-01
AU2003266413B2 (en) 2009-04-02
CN101481356B (en) 2012-07-11
CA2493794C (en) 2010-05-25
HK1174922A1 (en) 2013-06-21
SI1529032T1 (en) 2013-08-30
PT1529032E (en) 2013-07-11
CN1681774A (en) 2005-10-12
AR040964A1 (en) 2005-04-27
CA2493794A1 (en) 2004-02-26
US20070191407A1 (en) 2007-08-16
US7563922B2 (en) 2009-07-21
MY144894A (en) 2011-11-30
TW200418810A (en) 2004-10-01
US20060167253A1 (en) 2006-07-27

Similar Documents

Publication Publication Date Title
IS2980B (en) Methods for Preparation of 4 - [[4 - [[4- (2-cyanoethyl) -2,6-dimethylphenyl] amino] -2-pyrimidinyl] amino] benzonitrile
CY2016050I1 (en) 4-[[4-[[4-(2-CYANOETHENYL)-2,6-DIMETHYLPHENYL]AMINO]-2-PYRIMIDINYL]AMINO]BENZONITRIUM SALT
PL1632232T6 (en) Salt of 4[[4-[[4-(2-Cyanoethenyl)-2,6-dimethylphenyl]amino]-2-Pyrimidinyl]amino]benzonitrile
DK1259513T3 (en) New crystalline form of N- [4- [2- (2-amino-4,7-dihydro-4-oxo-3H-pyrrolo [2,3-d] pyrimidin-5-yl) ethyl] benzoyl] -L- glutamic acid and methods for its preparation
ATE464898T1 (en) CYCLIC PROTEIN TYROSINE KINASE INHIBITORS
DK2175857T3 (en) Crystalline Form of (E) 4 - [[4 - [[4- (2-CYANOETHENYL) -2,6-DIMETHYLPHENYL] AMINO] -2-PYRIMIDINYL] AMINO] BENZONITRIL
DE60201859D1 (en) Pharmaceutical use of N-carbamoylazole derivatives
EE200300400A (en) Pyrimidine compounds, process for their preparation and use
ATE477803T1 (en) METABOLITE OF QUETIAPINE
DK1578731T3 (en) Process for Preparation of Pyrimidine Compounds
AP2296A (en) Hydrochloride of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2-pyrimidinyl]amino]benzonitrile.
AP2487A (en) Fumarate of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]-amino]-2-pyrimidinyl]amino]benzonitrile
CR9032A (en) 4 - ((4 - ((4- (2-CYANETHETHYL)) -2,6-DIMETHYLPHENYL) AMINO-2- PYRIMIDINYL) AMINO) BENZONITRILE FUMARATE
PL356895A1 (en) Method of manufacture of n-(4-cyano-3-trifluoromethylo phenylo)-2,3-epoxy-2-methyl prop anamide
PT1490363E (en) PREPARATION PROCESSES OF 2- (7-CHLORO-1,8-NAFTHYRIDINE-2-YL) -3- (5-METHYL-2-OXO-HEXYL) -1-ISOINDOLINONE
AU2003206121A8 (en) Preparation of 4-(n, n-disubstitutedamino) butyraldehyde acetals
ITRM20010736A1 (en) OSTEO INTEGRATED SYSTEM OF ADJUSTABLE LENGTH AND A KIT FOR ITS PREPARATION.
ITMI20020620A1 (en) PROCEDURE FOR THE PREPARATION OF ALCHYL-BENZOATES FOR THE EXTERIFICATION OF BENZOIL-FLUORIDES